018499564

DAIM

---

June 23, 2021

Trademark Summary

The trademark DAIM was filed by Daim Pharma Ltd, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on August 18, 2021, and received one opposition filed on November 18, 2021 by GP Pharm S.A. on Likelihood of confusion. the opponent was represented by CLARKE, MODET Y CÍA., S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 18, 2021

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Chemical preparations for the diagnosis of diabetes
  2. Pharmaceutical preparations for the prevention of diabetes
  3. Pharmaceutical preparations for treating diabetes
  4. Pharmaceutical preparations for the prevention of diseases of the immune system
  5. Pharmaceutical preparations for the prevention of disorders of the immune system
  6. Pharmaceutical preparations for the treatment of immune system related diseases and disorders
  7. Pharmaceutical preparations for the treatment of autoimmune diseases
  8. Pharmaceutical preparations for the prevention of autoimmune diseases
  9. Pharmaceutical preparations for the treatment of autoimmune disorders
  10. Pharmaceutical preparations for the prevention of autoimmune disorders
  11. Pharmaceutical preparations for regulating the immune system
  12. Pharmaceutical preparations
  13. Chemical preparations for medical purposes
  14. All of the aforesaid goods being for the diagnosis, treatment, management or prevention of Type 1 diabetes.
• The mark was filed in class 10 with following description of goods:
  
  1. Medical test kits for diabetes monitoring for home use
  2. Testing instruments for medical diagnostic purposes
  3. Blood glucose testing apparatus
  4. Apparatus for carrying-out diagnostic tests for medical purposes
  5. Diagnostic, examination, and monitoring equipment
  6. Medical apparatus for testing the level of glucose in the blood
  7. Medical apparatus and instruments
  8. Medical diagnostic instruments
  9. Medical testing instruments
  10. All of the aforesaid goods being for use in the diagnosis, treatment, management or prevention of Type 1 diabetes.
• The mark was filed in class 35 with following description of goods:
  
  1. Advertising services relating to pharmaceuticals for the treatment of diabetes
  2. Advertising services relating to pharmaceuticals
  3. Advertising, marketing and promotional services
  4. Advertising
  5. Compilation of statistical data for use in scientific research
  6. Compilation of statistical data relating to medical research
  7. Advertising services to promote public awareness of medical conditions
  8. Advertising services related to immune disorders
  9. Advertising services related to autoimmune diseases
  10. All of the aforesaid services being provided in connection with the diagnosis, treatment, management or prevention of Type 1 diabetes.
• The mark was filed in class 44 with following description of goods:
  
  1. Diabetes screening services
  2. Medical services in the field of diabetes
  3. Providing information via the Internet in the field of diabetes
  4. Medical screening
  5. Health screening services
  6. Medical analysis services for diagnostic and treatment purposes provided by medical laboratories
  7. Medical services for the diagnosis of conditions of the human body
  8. Medical services
  9. Medical diagnostic services
  10. Medical services for the treatment of conditions of the human body
  11. Medical testing services relating to the diagnosis and treatment of disease
  12. Performing diagnosis of diseases
  13. Medical information services provided via the Internet
  14. Providing medical information
  15. Medical analysis services for autoimmune disease diagnosis and prognosis
  16. All of the aforesaid services relating to the diagnosis, treatment, management or prevention of Type 1 diabetes.